Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1245.50

-24.30 (-1.91%)

< Home < Back

Dr. Reddys Laboratories informs about press release

Date: 27-03-2019

Dr. Reddys Laboratories has informed that it has enclosed a Press Release on ' Dr. Rcddy's Laboratories launches Tadalafil Tablets USP in the US Market.'

The above information is a part of company’s filings submitted to BSE.